PTC Therapeutics, Inc.

533 articles with PTC Therapeutics, Inc.

• PTC Therapeutics, Inc. And CV Therapeutics, Inc. Announce Collaboration And License Arrangement; PTC To Receive Initial Payment Of $10 Million

  6/12/2006

• PTC Therapeutics, Inc. Initiates Phase 1A Clinical Trial Of PTC299

  5/12/2006

• PTC Therapeutics, Inc. Announces Promotion Of Claudia Hirawat

  4/21/2006

• PTC Therapeutics, Inc. Announces Interim Phase 2 Results Of PTC124 In Cystic Fibrosis

  4/4/2006

• PTC Therapeutics, Inc. Files For Initial Public Offering

  4/3/2006

• PTC Therapeutics, Inc. Receives Fast Track Designation For PTC124 In The Treatment Of Duchenne Muscular Dystrophy

  3/29/2006

• Schering-Plough Corporation And PTC Therapeutics, Inc. Announce Collaboration For Development Of PTC's Preclinical Hepatitis C Compounds

  3/20/2006

• PTC Therapeutics, Inc. Initiates Phase 2 Study Of PTC124 In Duchenne Muscular Dystrophy

  1/27/2006

• PTC Therapeutics, Inc. Initiates Second Phase 2 Study Of PTC124 In Patients With Cystic Fibrosis In Israel

  12/22/2005

• PTC Therapeutics, Inc. Names David P. Southwell To Its Board Of Directors

  12/19/2005

• PTC Therapeutics, Inc. Initiates Phase 2 Study Of PTC124 In Cystic Fibrosis

  12/6/2005

• FDA's Office Of Orphan Products Development Awards PTC Therapeutics, Inc. A Grant To Support Clinical Development Of PTC124 For The Treatment Of Nonsense-Mutation-Mediated Cystic Fibrosis

  12/6/2005

• PTC Therapeutics, Inc. Raises $26.6 Million In Private Placement Financing

  11/10/2005